1. Home
  2. NKTX vs ATLO Comparison

NKTX vs ATLO Comparison

Compare NKTX & ATLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTX
  • ATLO
  • Stock Information
  • Founded
  • NKTX 2015
  • ATLO 1903
  • Country
  • NKTX United States
  • ATLO United States
  • Employees
  • NKTX N/A
  • ATLO N/A
  • Industry
  • NKTX Biotechnology: Pharmaceutical Preparations
  • ATLO Major Banks
  • Sector
  • NKTX Health Care
  • ATLO Finance
  • Exchange
  • NKTX Nasdaq
  • ATLO Nasdaq
  • Market Cap
  • NKTX 170.8M
  • ATLO 166.6M
  • IPO Year
  • NKTX 2020
  • ATLO N/A
  • Fundamental
  • Price
  • NKTX $2.00
  • ATLO $17.71
  • Analyst Decision
  • NKTX Strong Buy
  • ATLO
  • Analyst Count
  • NKTX 6
  • ATLO 0
  • Target Price
  • NKTX $15.00
  • ATLO N/A
  • AVG Volume (30 Days)
  • NKTX 2.4M
  • ATLO 12.2K
  • Earning Date
  • NKTX 03-26-2025
  • ATLO 05-07-2025
  • Dividend Yield
  • NKTX N/A
  • ATLO 4.50%
  • EPS Growth
  • NKTX N/A
  • ATLO N/A
  • EPS
  • NKTX N/A
  • ATLO 1.14
  • Revenue
  • NKTX N/A
  • ATLO $53,455,000.00
  • Revenue This Year
  • NKTX N/A
  • ATLO N/A
  • Revenue Next Year
  • NKTX N/A
  • ATLO N/A
  • P/E Ratio
  • NKTX N/A
  • ATLO $15.66
  • Revenue Growth
  • NKTX N/A
  • ATLO 2.24
  • 52 Week Low
  • NKTX $1.31
  • ATLO $15.69
  • 52 Week High
  • NKTX $11.84
  • ATLO $22.03
  • Technical
  • Relative Strength Index (RSI)
  • NKTX 59.36
  • ATLO 42.98
  • Support Level
  • NKTX $1.31
  • ATLO $17.45
  • Resistance Level
  • NKTX $2.34
  • ATLO $17.99
  • Average True Range (ATR)
  • NKTX 0.15
  • ATLO 0.33
  • MACD
  • NKTX 0.05
  • ATLO -0.05
  • Stochastic Oscillator
  • NKTX 66.99
  • ATLO 25.00

About NKTX Nkarta Inc.

Nkarta Inc is a biopharmaceutical company engaged in developing engineered natural killer (NK) cells to treat cancer and autoimmune diseases. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer. The Company's operations are based in South San Francisco, California.

About ATLO Ames National Corporation

Ames National Corporation is a United States-based bank holding company. Through its subsidiaries, it provides checking, savings and time deposits, cash management services, merchant credit card processing, safe deposit boxes, wire transfers, direct deposit of payroll and social security checks, and automated/video teller machine access. Its loan portfolio comprises commercial, residential & agricultural real estate loans; agricultural & business operating loans & lines of credit; equipment loans; vehicle loans; personal loans; and mortgage loans. Its operations are conducted in central, north central, and south-central Iowa.

Share on Social Networks: